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ABSTRACT
The calmodulin (CaM)-dependent adenylyl cyclase (AC) toxin
from Bordetella pertussis (CyaA) substantially contributes to the
pathogenesis of whooping cough. Thus, potent and selective
CyaA inhibitors may be valuable drugs for prophylaxis of this
disease. We examined the interactions of fluorescent 2,3-N-
methylanthraniloyl (MANT)-, anthraniloyl- and trinitrophenyl
(TNP)-substituted nucleotides with CyaA. Compared with
mammalian AC isoforms and Bacillus anthracis AC toxin edema
factor, nucleotides inhibited catalysis by CyaA less potently.
Introduction of the MANT substituent resulted in 5- to 170-fold
increased potency of nucleotides. Ki values of 3MANT-2d-
ATP and 2MANT-3d-ATP in the AC activity assay using Mn2
were 220 and 340 nM, respectively. Natural nucleoside 5-
triphosphates, guanine-, hypoxanthine- and pyrimidine-MANT-
and TNP nucleotides and di-MANT nucleotides inhibited CyaA,
too. MANT nucleotide binding to CyaA generated fluorescence
resonance energy transfer (FRET) from tryptophans Trp69 and
Trp242 and multiple tyrosine residues, yielding Kd values of 300
nM for 3MANT-2d-ATP and 400 nM for 2MANT-3d-ATP.
Fluorescence experiments and docking approaches indicate
that the MANT- and TNP groups interact with Phe306. In-
creases of FRET and direct fluorescence with MANT nucleo-
tides were strictly CaM-dependent, whereas TNP nucleotide
fluorescence upon binding to CyaA increased in the absence of
CaM and was actually reduced by CaM. In contrast to low-
affinity MANT nucleotides, even low-affinity TNP nucleotides
generated strong fluorescence increases upon binding to
CyaA. We conclude that the catalytic site of CyaA possesses
substantial conformational freedom to accommodate structur-
ally diverse ligands and that certain ligands bind to CyaA even
in the absence of CaM, facilitating future inhibitor design.
Bordetella pertussis toxin CyaA is a 1706-amino acid viru-
lence factor interacting with surface receptors of eukaryotic
host cells and translocating its AC domain into the cytosol
(Confer and Eaton, 1982; Hewlett et al., 1989; Ladant and
Ullmann, 1999). After activation by calmodulin (CaM), an
endogenous calcium sensor, CyaA catalyzes massive synthe-
sis of cAMP (Mock and Ullmann, 1993; Shen et al., 2002;
Ahuja et al., 2004). cAMP inhibits phagocyte function and
facilitates respiratory tract infection by Bordetella pertussis
(Boyd et al., 2005; Carbonetti et al., 2005; Hewlett et al.,
2006). Substrate analogs may be used to inhibit the catalytic
activity of CyaA (Johnson and Shoshani, 1990; Soelaiman et
al., 2003; Gille et al., 2004) and prophylaxis of B. pertussis
infection. We have discovered N-methylanthraniloyl
(MANT)-substituted NTPs as competitive inhibitors of mam-
malian and bacterial ACs, including CyaA (Gille and Seifert,
2003; Gille et al., 2004). In addition, 2,3-(2,4,6-trinitrophe-
nyl) (TNP)-substituted NTPs are potent inhibitors of mam-
malian AC (Mou et al., 2006). Furthermore, adefovir, a drug
for the treatment of chronic hepatitis B virus infection, is a
potent CyaA inhibitor (Shen et al., 2004).
Mammals express nine membranous AC isoforms (ACs
1–9) and a soluble AC. We have employed the cytosolic
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catalytic domains C1 of type 5 AC and C2 of type 2 AC for
molecular AC analysis (Gille et al., 2004; Mou et al., 2005,
2006). Comparing the crystal structures of C1:C2 bound to
MANT-GTP, MANT-ATP, and TNP-ATP, we found the cat-
alytic site of AC to consist of three binding pockets, accom-
modating the base, the 2,3-ribosyl substituent and the
phosphate chain. We have also reported the crystal struc-
ture of CyaA in complex with CaM and 9-[2-(phosphono-
methoxy)ethyl]adenine diphosphate (PMEApp), the active
metabolite of adefovir (Guo et al., 2005). Forty-nine amino
acid residues of CyaA and 41 residues of CaM form salt
bridges, hydrogen bonds, and hydrophobic contacts, result-
ing in high affinity of CyaA for CaM (Kd  0.2 nM). How-
ever, the precise conformational changes in the catalytic
site of CyaA underlying its activation by CaM are still
unknown. An understanding of these processes will greatly
facilitate future inhibitor design.
To monitor nucleotide binding to and conformational
changes in CyaA, several different approaches can be em-
ployed. First, MANT- and ANT nucleotides are environ-
mentally sensitive probes displaying increased fluores-
cence and blue shift of the emission maximum upon
exposure to a hydrophobic environment (Hiratsuka, 1983;
Jameson and Eccleston, 1997). As is obvious from the CyaA
crystal structure in complex with PMEApp (Guo et al.,
2005), the catalytic site contains the hydrophobic residue
F306. Nucleotide binding to CyaA allows hydrophobic in-
teractions between the MANT/ANT group and Phe306,
resulting in an increased fluorescence signal (Sarfati et al.,
1990; Guo et al., 2005). This notion is supported by the fact
that CyaA-F306A does not increase the fluorescence signal
of 3ANT-2d-ATP (Guo et al., 2005). Second, the catalytic
domain of CyaA bears two tryptophan residues, Trp69 and
Trp242, located 21 and 38 Å, respectively, away from the
catalytic site (Guo et al., 2005). These distances allow
fluorescence resonance energy transfer (FRET) (Lakowicz,
1999) from tryptophan (excitation wavelength, 280 nm;
emission wavelength, 350 nm) to MANT (excitation wave-
length, 350 nm; emission wavelength, 450 nm) (Gilles et
al., 1990; Mou et al., 2005, 2006). Third, TNP nucleotides
are environmentally sensitive fluorescence probes, too
(Hiratsuka, 2003). Like MANT nucleotides, TNP nucleo-
tides show a blue shift in emission in a hydrophobic envi-
ronment (Hiratsuka, 2003). Compared with MANT/ANT
nucleotides, TNP nucleotides are more rigid because the
fluorophore is attached through both the 2- and the 3-
ribosyl positions, avoiding potential problems with fluoro-
phore isomerization (Jameson and Eccleston, 1997; Hirat-
suka, 2003). A potential advantage of TNP nucleotides
compared with MANT nucleotides is the fact that the
relative fluorescence increases can be substantially larger,
depending on the specific protein studied (Jameson and
Eccleston, 1997; Hiratsuka, 2003; Mou et al., 2005, 2006).
In the present study, we used MANT/ANT- and TNP nu-
cleotides as probes to determine their potencies at inhibiting
CyaA and to investigate conformational changes in the cat-
alytic site. Nucleotides 12, 14, 15, 18, 19, 20, 25, 30, and 31
represent newly synthesized fluorescent probes. Moreover,
the binding mode of nucleotides was explored by docking of
representative derivatives to a CyaA model derived from the
crystal structure in complex with PMEApp (Shen et al., 2004;
Guo et al., 2005).
Materials and Methods
Materials. MANT- and ANT-substituted NTPs of adenosine, cy-
tidine, inosine, and uridine were synthesized according to a docu-
mented procedure (Hiratsuka, 1983). The modification of the synthe-
sis by lowering the pH value from 9.6 to 8.6 induced higher yields. In
the case of the starting material methylisatoic anhydride, the major
portion of the excessive compound was removed by CHCl3 extraction.
In general, the separation of starting materials could be achieved by
using size exclusion chromatography with Sephadex LH-20 in water.
However, high-performance liquid chromatography analysis and liq-
uid chromatography/mass spectrometry coupling still showed by-
products of the corresponding (M)ANT-diphosphate residue. Pure
MANT nucleotides were obtained by preparative reversed-phase
HPLC with a Phenomenex Luna C18(2) column (particle size, 10 m;
length, 250 mm; inner diameter, 21.2 mm). The nucleoside 5-diphos-
phates were also collected because of their putative inhibitory ef-
fects. (M)ANT-nucleoside 5-diphosphates and triphosphates were
obtained in high purity of 99%. Di-MANT-IMP (31) bearing two
MANT groups at the 2,3-ribosyl position was also found as a by-
product of our synthesis and was purified to 99% content, too.
MANT-ATP (8), MANT-GTP (10), ANT-GTP (24), 3MANT-2d-
ATP (21), 2MANT-3d-ATP (22), TNP-CTP (28), TNP-UTP (29), and
S-substituted MANT nucleotides (9, 11, 13) were obtained from
Jena Bioscience (Jena, Germany). In the case of MANT-ATP, the
MANT group isomerizes between the 2 and 3 positions of the ribose
ring, whereas in 2MANT-3d-ATP and 3MANT-2d-ATP, the
MANT group is fixed to the corresponding position due to the ab-
sence of the neighboring hydroxyl group. PMEApp (1) was supplied
by Gilead Sciences (Foster City, CA). TNP-ATP (26) and TNP-GTP
(27) were from Invitrogen (Carlsbad, CA). ITP was from Sigma-
Aldrich (Seelze, Germany); GTP was from Roche (Mannheim, Ger-
many). UTP and CTP were from Boehringer Ingelheim (Ingelheim,
Germany). The catalytic domain of B. pertussis AC protein (CyaA,
amino acids 1–373) was purified as described previously (Shen et al.,
2002). Lyophilized calmodulin from bovine brain was purchased
from Calbiochem (Darmstadt, Germany). [-32P]ATP (800 Ci/mmol)
was purchased from PerkinElmer Life and Analytical Sciences,
Waltham, MA. Aluminum oxide 90 active, neutral (activity 1; parti-
cle size, 0.06–0.2 mm) was purchased from Merck (Darmstadt, Ger-
many). Albumin from bovine serum, fraction V, highest quality, was
from Sigma-Aldrich. MnCl2 tetrahydrate and MgCl2 hexahydrate
(highest quality) were from Merck.
FRET and Direct Fluorescence Experiments with MANT
Nucleotides. Experiments were performed using a quartz UV ultra-
microcuvette from Hellma (Mu¨llheim, Germany) (type 105.251-QS;
light path length, 3 mm; center, 15 mm; total volume, 70 l). Mea-
surements were performed in a Cary Eclipse fluorescence spectrom-
eter (Varian, Inc., Palo Alto, CA) at a constant temperature of 25°C
(slit width, 5 nm; scan rate, 120 nm/min; averaging time, 0.5 s; data
interval, 1 nm; PMT voltage, 700 V). The cuvette contained at first 64
l of 75 mM HEPES/NaOH buffer, 100 M CaCl2, 100 mM KCl, and
5 mM MnCl2, pH 7.4. Next, nucleotide, CyaA, and CaM were added
successively. The cuvette content (final volume, 70 l) was mixed
after each addition. In FRET experiments, nucleotides were used at
final concentrations from 10 nM to 2 M, and CyaA and CaM were
300 nM each. The excitation wavelength was 280 nm, and emission
was scanned from 300 to 550 nm. To investigate the kinetics of CyaA
interaction with MANT nucleotides, the excitation wavelength was
280 nm, and changes in fluorescence intensity were measured over
time at 430 nm. Nucleotides, CyaA, and CaM were applied at a final
concentration of 300 nM. MANT nucleotides were finally displaced
from CyaA using PMEApp (10 nM to 3 M). In saturation studies,
independent FRET experiments were performed using MANT nucle-
otides from 10 nM to 2 M final concentration; CyaA and CaM were
300 nM each. Saturation curves were obtained by subtracting the
fluorescence intensity at 430 nm after the addition of CyaA from the
maximal fluorescence (FRET) after the addition of CyaA/CaM.
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In direct fluorescence experiments, MANT nucleotides were ex-
cited at 350 nm, and emission spectra were recorded from 380 to 550
nm. To obtain large increases in direct fluorescence, CyaA and CaM
(final concentrations, 2.4 M) were used in excess relative to MANT
nucleotides (final concentration, 100 nM), ensuring complete binding
of the nucleotide to CyaA. For an estimation of the hydrophobic
properties of the binding site interacting with the MANT group,
direct fluorescence of the nucleotides was determined in water and in
30% (v/v) dimethyl sulfoxide.
Fluorescence Studies with TNP Nucleotides. Fluorescence
studies with TNP nucleotides were essentially performed as for
MANT nucleotides with some modifications. In particular, the con-
centrations of TNP nucleotides, CyaA, and CaM were each 5 M. The
higher protein concentrations were necessary to compensate for the
lower quantum yield with TNP nucleotides compared with MANT
nucleotides (Jameson and Eccleston, 1997; Hiratsuka, 2003). The
excitation wavelength was 405 nm, and emission was scanned from
480 to 620 nm.
AC Activity Assay. For the determination of the potency of CyaA
inhibitors, assay tubes contained 10 l of inhibitor at final concen-
trations from 10 nM to 100 M and 20 l of CyaA protein (final
concentration, 10 pM) in 75 mM HEPES/NaOH, pH 7.4, containing
0.1% (m/v) bovine serum albumin. Tubes were preincubated for 2
min at 25°C, and reactions were initiated by the addition of 20 l of
reaction mixture consisting of the following components to yield the
given final concentrations: 100 mM KCl, 10 M free Ca2, 5 mM free
Mn2 or Mg2, 100 M EGTA, 100 M cAMP, and 100 nM calmod-
ulin. ATP was added as nonlabeled substrate at a final concentration
of 40 M and as radioactive tracer [-32P]ATP (0.2 Ci/tube). For the
determination of Km and Vmax values, 10 M to 2 mM ATP/Mn
2 or
ATP/Mg2 were added, plus 5 mM free Mn2 or Mg2. To ensure
linear reaction progress, tubes were incubated for 10 min at 25°C,
and reactions were stopped by the addition of 20 l of 2.2 N HCl.
Denaturated protein was sedimented by a 1-min centrifugation at
12,000g. [32P]cAMP was separated from [-32P]ATP by transferring
the samples to columns containing 1.4 g of neutral alumina.
[32P]cAMP was eluted by the addition of 4 ml of 0.1 M ammonium
acetate solution, pH 7.0. Blank values were approximately 0.02% of
the total added amount of [-32P]ATP; substrate turnover was 3%
of the total added [-32P]ATP. Samples collected in scintillation vials
were filled up with 10 ml of double-distilled water and Cˇerenkov
radiation was measured in a Tri-Carb 2800TR liquid scintillation
analyzer (PerkinElmer Life and Analytical Sciences).
Free concentrations of divalent cations were calculated with Win-
MaxC (http://www.stanford.edu/cpatton/maxc.html). Ki values re-
ported in Table 1 and Kd values obtained from saturation experi-
ments were calculated using the Prism 4.02 software (GraphPad,
San Diego, CA).
TABLE 1
Potencies of inhibitors at CyaA
AC toxin activities were determined as described under Materials and Methods. Apparent Km and Vmax values were obtained by nonlinear regression analysis of
substrate-saturation experiments and are the means  S.E.M. of three to five independent experiments. Km values are given in micromolar, Vmax values are given as molar
turnover numbers (s1). Ki values are given in micromolar and are the means  S.E.M. of at least three experiments performed in duplicate. For determination of the
inhibitory potencies of various purine and pyrimidine nucleotides, reaction mixtures contained 100 mM KCl, 10 M free Ca2, 5 mM free Mn2 or Mg2, 100 M EGTA, 40
M ATP, 0.2 Ci/tube - 32P	ATP, 100 M cAMP, 100 nM calmodulin, 10 pM CyaA in 75 mM HEPES/NaOH, pH 7.4, and nucleotides at concentrations from 100 pM to 2
mM as appropriate to construct concentration-response curves. The Ki value for 1 under Mg
2-conditions was taken from Shen et al. (2004). The Ki values for 4, 7, and 17
under Mn2-conditions were taken from Gille et al. (2004). Inhibition curves were analyzed by non-linear regression using the Prism 4.02 software (GraphPad Software, San
Diego, CA).
Compound
Ki
Mn2 Mg2
M
ATP 45  6a 609  62a
ATP 165  21b 861  106b
1 PMEApp 0.001  0.0003 0.025  0.002
2 GTP 27  6 260  32
3 ITP 100  20 1,100  220
4 ITPS 77 ND
5 CTP 35  1 270  43
6 UTP 120  14 330  80
7 UTPS 36 ND
8 MANT-ATP 4.3  0.4 51  1
9 MANT-ATPS 1.2  0.4 15  2
10 MANT-GTP 5.9  1.0 16  2
11 MANT-GTPS 5.4  0.5 7.4  0.1
12 MANT-ITP 0.6  0.1 16  4
13 MANT-ITPS 1.8  0.3 31  2
14 MANT-CTP 1.1  0.1 36  4
15 MANT-UTP 2.6  0.3 42  9
16 MANT-ADP 12  2 91  16
17 MANT-GDP 60 ND
18 MANT-IDP 11  3 
100
19 MANT-CDP 18  3 
100
20 MANT-UDP 43  1 
100
21 3MANT-2d-ATP 0.2  0.04 32  7
22 2MANT-3d-ATP 0.3  0.04 22  4
23 ANT-ATP 1.3  0.1 20  3
24 ANT-GTP 29  0.3 
100
25 ANT-ADP 11  1 
100
26 TNP-ATP 6.5  0.2 110  23
27 TNP-GTP 20  3 320  7
28 TNP-CTP 10  0.4 410  9
29 TNP-UTP 58  8 780  38
30 MANT-IMP 
100 
100
31 Di-MANT-IMP 20  3 37  3
a Km values (micromolar).
b Vmax values (seconds
1).
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Modeling of the Nucleotide Binding Mode to CyaA. Docking
studies were performed with the molecular modeling package
SYBYL 7.3 (Tripos Inc., St. Louis, MO) on an Octane workstation
(SGI, Mountain View, CA. An initial computer model of CyaA in
complex with PMEApp was generated from the PDB crystal struc-
ture 1zot (Guo et al., 2005). Hydrogens were added and AM-
BER_FF99 charges were assigned to the protein and the water
molecules, followed by a rough preoptimization of the model (100
cycles) with the AMBER_FF99 force field (Cornell et al., 1995) and
fixed PMEApp. The three Mg2 ions received formal charges of 2.
Starting conformations of 3MANT-2d-ATP (21), 2MANT-3d-ATP
(22), and TNP-ATP (26) were derived from complexes of 3MANT-
ATP and TNP-ATP with mammalian AC (PDB structures 2gvz and
2gvd, respectively) (Mou et al., 2005, 2006). PMEApp and the ligands
21, 22, and 26 were provided with Gasteiger-Hueckel charges. Initial
docking positions resulted from superposition of roughly optimized
conformations with PMEApp, allowing the modification of rotatable
bonds, and from consideration of the fluorescence data (interaction of
the MANT- and TNP-groups with Phe306). Water molecules in the
catalytic site were removed. Each complex was refined in a stepwise
approach. First, 50 minimization cycles with fixed ligand (AM-
BER_FF99 force field, steepest descent method) were performed;
second, 100 minimization cycles of the ligand and the surrounding
(distance up to 6 Å) protein residues (Tripos force field) (Clark et al.,
1989), and, third, 100 minimization cycles with fixed ligand (AM-
BER_FF99 force field, Powell conjugate gradient). The second and
third steps were repeated with larger number of cycles until an
root-mean-square force of 0.05 kcal/mol  Å-1 was approached. To
avoid overestimation of electrostatic interactions, a distance-depen-
dent dielectric constant of 4 was applied. Molecular surfaces and
lipophilic potentials [protein variant with the new Crippen parame-
ter table (Heiden et al., 1993; Ghose et al., 1998)] were calculated and
visualized by the program MOLCAD (MOLCAD, Darmstadt, Ger-
many) contained within SYBYL.
Results
Overview on Nucleotide Structures. We examined the
inhibitory effects of 31 nucleotides on the catalytic activity of
CyaA (Table 1). Nucleotides differed from each other in base,
phosphate chain length, phosphate chain substitution, and
MANT, ANT, or TNP substituents at the 2,3-ribosyl position.
In compounds 8–20, 23–25, and 30, the MANT- or ANT group
undergoes spontaneous isomerization between the 2- and 3-
ribosyl position (Jameson and Eccleston, 1997). In 21 and 22,
the MANT group is fixed to the 2- or 3-position because the
neighboring ribosyl position is deoxygenated, thus preventing
isomerization. In 23–25, an ANT group is attached to the ribo-
syl residue instead of the MANT group. Compounds 26–29
contain TNP substituents. Because the TNP-group is attached
to the ribosyl ring via the 2- and 3-position, isomerization is
not possible in TNP nucleotides (Hiratsuka, 2003). In 31, two
MANT-substituents are attached to the 2- and 3-ribosyl posi-
tion. In 9, 11 and 13, the -phosphate group is substituted by a
-thiophosphate group. The potencies of the different nucleo-
tides were determined in the AC activity assay in the presence
of either Mn2 or Mg2.
Structure/Activity Relationships under Mn2 Condi-
tions. Under Mn2 conditions, MANT-ITP (12) displayed the
highest potency of all MANT-NTPs examined, exhibiting 7-fold
higher potency than MANT-ATP (8). The rank order of poten-
cies was MANT-ITP 
 MANT-CTP 
 MANT-UTP 
 MANT-
ATP 
 MANT-GTP. MANT-GTP (10) exhibited 10-fold lower
potency compared with MANT-ITP. For MANT-NDPs, the or-
der of potency was MANT-IDPMANT-ADP
MANT-CDP

MANT-UDP; MANT-IDP was 4-fold more potent than MANT-
UDP. For ANT nucleotides, the adenine base was advantageous
compared with guanine; ANT-ATP (23) was 22-fold more potent
than ANT-GTP (24). Among S-substituted MANT nucleotides,
the rank order of potency was MANT-ATPS 
 MANT-
ITPS 
 MANT-GTPS; MANT-ATPS (9) was 4- to 5-fold
more potent than MANT-GTPS (11).
TNP-ATP (26) was the most potent TNP nucleotide; the rank
order was TNP-ATP 
 TNP-CTP 
 TNP-GTP 
 TNP-UTP.
Among the nucleotides bearing no fluorescent substituent at
the 2,3-ribosyl position, GTP (2) displayed the highest affinity,
which was 4-fold higher than the affinity of ITP (3) and UTP (6).
Interestingly, theKi constants of GTP and CTP were lower than
the Km value of the natural substrate ATP. Compared with the
nonsubstituted NTPs, the MANT group increased inhibitor po-
tency 5-fold, 31-fold, 45-fold, and 166-fold for MANT-GTP,
MANT-CTP, MANT-UTP, and MANT-ITP, respectively. The
TNP group increased inhibitory potency in the case of TNP-CTP
and TNP-UTP just by factors of 3 and 2, respectively, and
TNP-GTP (27) was only slightly more potent than GTP (2).
MANT-substituted nucleotides were 2, 3, 9, and 22 times more
potent in inhibiting CyaA compared with TNP nucleotides (8
versus 26, 10 versus 27, 14 versus 28, and 15 versus 29, re-
spectively). Although ANT-ATP (23) was 3-fold more potent
than MANT-ATP (8), the potency of ANT-GTP (24) was 5-fold
lower compared with MANT-GTP (10).
Omission of the -phosphate group resulted in substan-
tially decreased potencies at all nucleotides. Specifically,
MANT-ADP (16) was 3-fold less potent than MANT-ATP (8),
MANT-GDP 10-fold less than MANT-GTP (Gille et al., 2004),
MANT-CDP (19) 15-fold less than MANT-CTP (14), MANT-
UDP (20) 17-fold less than MANT-UTP (15), and MANT-IDP
(18) 18-fold less than MANT-ITP (12). ANT-ADP (25) was
9-fold less potent than ANT-ATP (23).
Adding the S-substitution to MANT-NTPs decreased po-
tency of MANT-ITP 3-fold (12 versus 13), increased potency of
MANT-ATP 4-fold (8 versus 9), and left the potency of MANT-
GTP unchanged (10 versus 11). Most strikingly, 3MANT-2d-
ATP (21) and 2MANT-3d-ATP (22) were 22- and 14-fold more
potent, respectively, than MANT-ATP (8).
Structure/Activity Relationships under Mg2 Condi-
tions. The exchange of Mn2 by Mg2 increased Km and Vmax
by 14- and 5-fold, respectively. Inhibitory potencies of all tested
nucleotides were differentially lowered when Mg2 was used
instead of Mn2. While the potency of MANT-GTPS was only
minimally reduced, 3MANT-2d-ATP and 2MANT-3d-ATP
showed 160-fold and 70-fold lower potency with Mg2. The
rank order of potency for MANT-substituted NTPs was MANT-
GTP  MANT-ITP 
 MANT-CTP 
 MANT-UTP 
 MANT-
ATP. Whereas MANT-GTP (10) displayed the lowest potency of
all MANT-NTPs under Mn2-conditions, it was—together with
MANT-ITP (12)—the most potent MANT-NTP when Mg2 was
used. ANT-ATP (23) was 3-fold more potent than MANT-ATP
(8) and exceeded ANT-GTP (24) in potency. MANT-GTPS (11)
was the most potent S-substituted nucleotide tested, being
2-fold more potent than MANT-ATPS (9) and 4-fold more
potent than MANT-ITPS (13). The introduction of the MANT
group increased the potency of CTP, UTP and GTP by 7- to
16-fold. Most strikingly, MANT-ITP (12) was 70-fold more
potent than ITP (3). Among TNP nucleotides, potency de-
creased in the order TNP-ATP, TNP-GTP, TNP-CTP, and TNP-
UTP. It is noteworthy that the TNP group did not increase
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potency compared with nonsubstituted NTPs; potency even de-
creased (2 versus 27, 5 versus 28, and 6 versus 29).
FRET Experiments with MANT Nucleotides. In FRET
experiments, 2MANT-3d-ATP, 3MANT-2d-ATP, and
MANT-ATP (final concentrations, 300 nM each) were added
first to the buffer, and autofluorescence of MANT nucleotides as
a result of excitation at 280 nm was detected at 450 nm (Fig. 1,
dotted line). When CyaA was added, tryptophan and tyrosine
fluorescence occurred at 350 nm (Fig. 1, solid line). Upon addi-
tion of CaM, FRET (decrease in emission at 350 nm and in-
crease in emission at 430 nm) occurred for 2MANT-3d-ATP
and 3MANT-2d-ATP (Fig. 1, A and B, dashed lines), but not
for MANT-ATP (Fig. 1C), MANT-GTP, MANT-ITP, MANT-
CTP, and MANT-UTP (data not shown). When FRET experi-
ments were performed using the tryptophan-specific excitation
wavelength of 295 nm (Lakowicz, 1999), fluorescence intensity
at 350 nm decreased 3- to 4-fold. The relative magnitude of
FRET with 2MANT-3d-ATP and 3MANT-2d-ATP remained
unchanged upon tryptophan-selective excitation (data not
shown). Thus, FRET resulted from excitation of Trp69 and
Trp242 and tyrosine residues. Tyr75, Tyr122, Tyr263, Tyr333,
Tyr345, and Tyr350 are located in a distance of less than 20 Å
from the catalytic site. Thus, to obtain high FRET signals, it is
favorable to excite both tyrosine and tryptophan residues.
PMEApp (1) inhibited FRET in a concentration-dependent
manner (Fig. 2). Half-maximal displacement of 300 nM
3MANT-2d-ATP occurred at a PMEApp concentration of
approximately 50 nM, which is compatible with the notion
that PMEApp is a much more potent CyaA inhibitor than
3MANT-2d-ATP (Table 1). Kinetics of CyaA FRET stimu-
lation by CaM and inhibition by PMEApp occurred within
mixing time (few seconds). These data show that FRET was
specific and reversible.
By determining FRET with MANT nucleotides at increas-
ing concentrations after addition of CaM, saturation curves
were obtained (Fig. 3). Apparent Kd values were 400 nM for
2MANT-3d-ATP (A) and 300 nM for 3MANT-2d-ATP (B).
For MANT-ATP, MANT-GTP, MANT-ITP, MANT-CTP, and
MANT-UTP, Kd values could not be determined because of
absent or minimal FRET (data not shown). Thus, MANT
isomerization may impede energy capture of the fluorophore
from tryptophan and tyrosine residues.
We used CyaA at a final concentration of just 300 nM in an
assay volume of 70 l in FRET studies, corresponding to 0.8 g
of CyaA for one measurement. Because the consumption of
protein is low, because the production of CyaA can be accom-
plished at large scale (Shen et al., 2002) and because kinetics
occur within seconds (Fig. 2), fluorimetric high-throughput
screening of potential novel inhibitors is feasible, avoiding the
use of radioactive AC assays. Because fluorescent nucleotides
(e.g., 3MANT-2d-ATP) were competitively displaced from
CyaA by PMEApp (Fig. 2), the affinity of nonlabeled inhibitors
may also be estimated using this approach. In saturation ex-
periments (Fig. 3), apparentKd values were estimated to be 400
nM for 2MANT-3d-ATP (A) and 300 nM for 3MANT-2d-ATP
(B). The results from FRET experiments are in good agreement
with the corresponding Ki values determined in the AC activity
assay (Table 1).
Direct Fluorescence Experiments withMANTNucle-
otides. Nucleotides were excited at 350 nm and emission
Fig. 1. Monitoring of MANT nucleotide binding to the catalytic site of CyaA
using FRET. The assay buffer consisted of 75 mM HEPES/NaOH, 100 M
CaCl2, 100 mM KCl, and 5 mM MnCl2,pH 7.4. Nucleotides (A, 2MANT-3d-
ATP; B, 3MANT-2d-ATP; C, MANT-ATP) were added to the buffer to yield
a final concentration of 300 nM, and emission was scanned at an excitation
wavelength of 280 nm. CyaA protein and calmodulin were added succes-
sively to yield a final concentration of 300 nM. Shown are superimposed
recordings of a representative experiment. Similar data were obtained in
three independent experiments. a.u., arbitrary unit.
Fig. 2. Time-resolved activation of CyaA by CaM and stepwise abolish-
ment of FRET by PMEApp. Excitation wavelength was 280 nm and
emission was detected at 430 nm over time. 300 nM 3MANT-2d-ATP (1),
300 nM CyaA protein (2), 300 nM CaM (3), and PMEApp in the given
final concentrations (addition steps 4, 10 nM; 5, 30 nM; 6, 70 nM; 7, 1.6
M) were added in sequence. A recording of a representative experiment
is shown. Similar data were obtained in four independent experiments.
a.u., arbitrary unit.
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was scanned from 380 to 550 nm. Addition of CyaA to cu-
vettes containing 2MANT-3d-ATP or 3MANT-2d-ATP did
not increase their intrinsic fluorescence (Fig. 4, A and B).
However, upon addition of CaM, fluorescence increased by
120 and 130%, respectively. Moreover, the emission maxi-
mum of 2MANT-3d-ATP and 3MANT-2d-ATP showed a
shift to shorter wavelengths (blue shift). Under these condi-
tions, MANT-ATP fluorescence increased by only approxi-
mately 40% (data not shown). For comparison, direct fluores-
cence of nucleotides was determined in a polar environment
(water) and a hydrophobic environment [30% (v/v) dimethyl
sulfoxide]. Fluorescence of 100 nM 3MANT-2d-ATP in-
creased by 160% when exposed to dimethyl sulfoxide (Fig.
4C). In addition, the emission maximum shifted to shorter
wavelengths. Thus, binding of MANT nucleotides to CyaA
transferred the MANT group into a hydrophobic environ-
ment, probably facilitating interaction with Phe306 (Guo et
al., 2005).
Fluorescence Experiments with TNP Nucleotides.
When excited at a wavelength of 405 nm, TNP-ATP, TNP-
GTP, TNP-CTP, and TNP-UTP showed a fluorescence peak
at 550 nm (Fig. 5). The addition of CyaA to cuvettes con-
taining TNP nucleotides increased fluorescence by 3- to
5-fold, with TNP-ATP and TNP-GTP showing the largest
increases (Fig. 5, A and B). The fluorescence increases with
TNP nucleotides were virtually instantaneous after CyaA
addition (data not shown), indicative for rapid nucleotide/
protein interaction. Moreover, we observed a blue shift of the
emission maximum of TNP nucleotides to 540 nm. These
data indicate that binding of TNP nucleotides to CyaA trans-
fers the TNP-group into a hydrophobic environment. Fur-
thermore, and in striking contrast to the results obtained
with MANT nucleotides (Figs. 2–4), addition of CaM to CyaA
reduced TNP nucleotide fluorescence. This reduction in flu-
orescence was dependent on the specific nucleotide studied;
TNP-ATP showed the smallest relative reduction (Fig. 5A),
and TNP-CTP and TNP-UTP showed the largest relative
reductions (Fig. 5, C and D).
Modeling of the Binding Modes of MANT- and TNP
Nucleotides to CyaA. The crystal structure of CyaA in
complex with CaM and PMEApp (Guo et al., 2005) offered us
the possibility of predicting the binding mode of MANT and
TNP nucleotides. The AC domain of CyaA contains the cat-
alytic site at the interface of two structural domains, CA
(Met1–Gly61, Ala187–Ala364) and CB (Val62–Thr186). Com-
pared with PMEApp, the substrate ATP and the fluorescent
nucleotides are conformationally restricted because of the
semirigid ribosyl moiety. However, the spacious cavity be-
tween CA and CB may accommodate the different scaffolds so
that an alignment of the adenine base and the terminal
Fig. 3. Saturation curves of 2MANT-3d-ATP and 3MANT-2d-ATP
binding to activated CyaA. Each data point was determined in an inde-
pendent experiment as described under Materials and Methods. Final
concentrations of CyaA and CaM were 300 nM each. The fluorescence
increase at 430 nm was calculated by subtracting the fluorescence at 430
nm after addition of CyaA from the maximal fluorescence at 430 nm after
addition of CyaA/CaM. Data were analyzed by nonlinear regression using
the Prism 4.02 software. Similar data were obtained in three independent
experiments. a.u., arbitrary unit.
Fig. 4. Direct fluorescence of MANT nucleotides. The excitation wave-
length was 350 nm, and emission was scanned from 380 to 550 nm. 100
nM nucleotide, 2.4 M CyaA, and 2.4 M CaM were added to cuvettes A
and B in sequence. To mimic binding of the MANT group to a hydrophobic
binding pocket, 3MANT-2d-ATP was directly excited in water plus
dimethyl sulfoxide (DMSO) 30% (v/v) (C). Shown are superimposed re-
cordings of a representative experiment. Similar data were obtained in
five independent experiments. a.u., arbitrary unit.
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phosphates is possible (Fig. 6A). It becomes obvious that
hydrophobic interactions, especially of the lipophilic edge of
the desoxyribosyl moiety with Leu60 and of the 3MANT
group with Phe306, significantly contribute to the binding of
3MANT-2d-ATP (21) to CyaA (Table 1 and Fig. 3B). In fact,
nonsubstituted NTPs exhibited 5- to 170-fold lower affinities
than their MANT-substituted analogs (e.g., ITP versus
MANT-ITP), and CyaA-F306A failed to increase the fluores-
cence signal of 3ANT-2d-ATP (Guo et al., 2005).
However, why is PMEApp (1) 4 orders of magnitude more
potent at inhibiting CyaA than the natural and S-substi-
tuted NTPs (2-7) if the alignment indicates similar interac-
tions? First, a reasonable superposition of the phosphates
and the adenine bases as shown in Fig. 6A is only possible if
the conformation of the nucleotide moiety retains a certain
strain of approximately 3 kcal/mol. A complete minimization
would displace the adenine base and, in particular, the phos-
phate groups from their optimal positions. Therefore, the
“true” fit must be a balance between conformational strain
and binding energy. Second, the ethoxy oxygen of PMEApp
strongly interacts with Glu301 and Asn304 via a water mol-
ecule, and the ethylene bridge is also in close contact with the
edge of Phe306.
Fig. 6B represents the docking of 3MANT-2d-ATP (21)
into CyaA in more detail. The desoxyribosyl ring adopts a
3-exo conformation like the ribosyl moiety of MANT-ATP in
complex with mammalian AC (Mou et al., 2006). The three
Mg2 ions are in positions similar to those in the CyaA-
PMEApp complex and form the same interactions. Two of
them are coordinated with Asp188 and Asp190, one addition-
ally with His298, and the third with the - and -phosphate.
The imidazolyl-NH of His298 may be H-bonded with an ox-
ygen of the -phosphate. The -phosphate contacts the lysine
residues Lys65 and Lys58 (O-N distances, 2.8 Å). These
interactions account for the higher inhibitory potencies of the
triphosphates compared with the diphosphate and mono-
phosphate analogs in Table 1.
The adenine moiety is sandwiched between the side
chains of His298 and Asn304 whose amide NH2 group may
form an additional H bond with the desoxyribosyl ring
oxygen. The 6-amino substituent is in proximity to the
backbone oxygens of Val271, Gly299, and Thr300. How-
ever, the loop between Gly299 and Asn304 may align all of
the nucleobases in similar position. In the case of GTP,
ITP, UTP, and their MANT- and TNP-derivatives, back-
bone NH functions of, for example, Gly299 and Val271
could serve as hydrogen donors for the carbonyl oxygens in
the 6 and 4 positions, respectively. This diversity of possi-
ble interactions may account for the relatively small and
inconsistent potency differences when comparing the im-
pact of base substitution in different subsets of nucleotides
[i.e., natural NTPs, MANT-NTPs, MANT-NDPs and TNP-
NTPs (see Table 1)]. In addition, the affinity of each nu-
cleotide may be affected by a specific arrangement of water
molecules that cannot be simply transferred from the
PMEApp-bound CyaA structure.
Fig. 6B also shows that the high potency of 3MANT-2d-
ATP (21) is due in particular to ideal stacking of the phenyl
rings of the inhibitor and Phe306. This stacking also ac-
counts for the efficient FRET and direct fluorescence ob-
served with 3MANT-2d-ATP (Figs. 1–4). The axial posi-
tion of the hydrogen atom corresponding to the 2-OH
group in 3MANT-ATP suggests that even the 2,3di-
MANT-ATP derivative will be similarly potent because the
2-MANT moiety may fit into a hydrophobic site consisting
of Pro305 and Phe261.
This site would also be occupied by the 2-MANT group in
2MANT-3d-ATP (22) if the desoxyribosyl ring adopts a 3-
exo conformation. However, similar potencies of the posi-
tional isomers 21 and 22 in the AC assay (Table 1) and
fluorescence assay (Fig. 3) as well as similar magnitudes of
FRET and direct fluorescence (Figs. 1 and 4) rather indicate
analogous interactions between the MANT group and
Phe306 in the complexes of CyaA with 2MANT-3d-ATP and
3MANT-3d-ATP, respectively. Fig. 6C illustrates that dock-
ing of 2MANT-3d-ATP may indeed reproduce the interac-
Fig. 5. Fluorescence analysis of the interactions
of TNP nucleotides with CyaA. The excitation
wavelength was 405 nm, and emission was
scanned from 480 to 620 nm. 5 M nucleotide, 5
M CyaA, and 5 M CaM were added to the
cuvette in sequence. A, TNP-ATP; B, TNP-GTP;
C, TNP-CTP; D, TNP-UTP. Shown are superim-
posed recordings of a representative experiment.
Similar data were obtained in three to five inde-
pendent experiments. a.u., arbitrary unit.
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tion pattern of 3MANT-2d-ATP with CyaA shown in Fig.
6B. The only difference is a 3-endo conformation of the
desoxyribosyl moiety as is present, e.g., in A-DNA.
Fig. 6D shows the predicted binding mode of TNP-ATP
(26), which has a potency similar to that of the isomerizing
MANT-ATP derivative 8. Despite the rigidity of the tricy-
clic TNP-ATP scaffold, which contained a spiro junction, a
sufficient alignment with 3MANT-2d-ATP is possible so
that the phosphate groups, the adenine base, and the
phenyl moieties may interact with the same CyaA sites.
This superposition implies a relatively deep position of
TNP-ATP in the cavity. The interaction of Phe306 with the
TNP group is weaker than with MANT (no optimal posi-
tion, lower hydrophobicity). However, hydrogen bonds of
two ribosyl oxygens with the side chains of His298 and
Asn304, respectively, may counterbalance, in part, the
reduced hydrophobic interactions and higher conforma-
tional strain. In addition, the intrinsic fluorescence prop-
erties of TNP nucleotides (i.e., higher fluorescence in-
creases upon transfer into a hydrophobic environment
than with MANT nucleotides) (Jameson and Eccleston,
1997; Hiratsuka, 2003) more than compensate for the sub-
optimal positioning of the TNP-group relative to Phe306,
allowing for the detection of larger fluorescence increases
than with MANT nucleotides (Figs. 4 and 5). It is notewor-
thy that the inhibitory potency of TNP derivatives 26–29 is
more dependent on the specific nucleobase than in the
corresponding subseries of MANT nucleotides 8, 10, 14,
and 15 and the unsubstituted NTPs GTP (2), CTP (5), and
UTP (6). The rigid scaffold of the TNP nucleotides probably
does not enable an optimal fit of guanine and the pyrimi-
dines to the backbone of the loop between Gly299 and
Asn304.
The lower substrate Km and Vmax values as well as the
generally 5- to 40-fold higher potency of the inhibitors under
Mn2 conditions than under Mg2 conditions clearly point to
considerably tighter binding with the former cation. This
increase in the free energy of binding of up to 2 kcal/mol
should be due mainly to stronger Mn2-phosphate binding.
No further conclusions can be drawn from the docking ap-
proaches based on force field methods and without a CyaA
crystal structure with Mn2 instead of Mg2.
Discussion
Spacious Catalytic Site of CyaA. The catalytic site of
CyaA forms a large cavity with substantial conformational
freedom to accommodate structurally diverse ligands. In par-
ticular, not only adenine nucleotides but also other purine
and even pyrimidine nucleotides reduce the catalytic activity
Fig. 6. Docking of representative MANT- and TNP nucleotides to CyaA. The models are based on the crystal structure of CyaA in complex with
PMEApp, PDB 1zot (Guo et al., 2005) (clockwise arrangement of the images for better comparability of B and C). Colors of atoms, unless otherwise
indicated: orange, phosphorus; red, oxygen; blue, nitrogen; white, carbon; gray, hydrogen; green spheres, magnesium. A, overview of the binding site,
represented by the lipophilic potential mapped onto a MOLCAD Connolly surface (brown, hydrophobic areas; green and blue, polar areas). Docked
ligands: PMEApp (carbon atoms in magenta); 3MANT-2d-ATP (carbon and hydrogen atoms in yellow). B, docking of 3MANT-2d-ATP (21). Amino
acids within a sphere of 3 Å around the ligand are labeled. The protein backbone is schematically represented by a tube. Carbon atoms of the
backbone are colored in dark cyan; carbon atoms of the side chains are in light cyan. C, docking of 2MANT-3d-ATP (22). Representation of the
backbone and the side chains as in B. For clarity, some labels are omitted (see B). D, docking of TNP-ATP (26). For comparison, 3MANT-2d-ATP is
shown in the same position like in B (all atoms colored in magenta). Only amino acids with suggested interactions specific for TNP-ATP are labeled.
Representation of the backbone and the side chains as in B.
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of CyaA (Table 1) because of flexible fit to the backbone of the
loop between Gly299 and Asn304 (Fig. 6). Effective interac-
tion of CyaA with purine and pyrimidine nucleotides is also
clearly documented in the fluorescence experiments with
TNP-ATP, TNP-GTP, TNP-CTP, and TNP-UTP (Fig. 5),
monitoring interaction of the TNP-group with Phe306 (Fig.
6D). The distinct fluorescence responses upon interaction of
CyaA with various TNP nucleotides in the absence and pres-
ence of CaM are indicative for slightly different orientations
of TNP nucleotides in the catalytic site of CyaA. Moreover,
various MANT nucleotides (12–15) exhibiting higher affinity
for CyaA than TNP nucleotides (Table 1) did not give rise to
FRET with CyaA. These findings suggest that differences in
affinity do not account for the different fluorescence re-
sponses with various nucleotides. Rather, the differences in
fluorescence properties point to differences in orientation of
the nucleotides in the catalytic site. Taken together, all those
findings are in accordance with the modeling data and sup-
port the notion of a spacious catalytic site of CyaA.
Toward the Development of Selective CyaA Inhibi-
tors. Because the inhibitory profile of CyaA differs consider-
ably from that of mammalian ACs (Gille et al., 2004; Mou et
al., 2005, 2006), development of more potent and selective
CyaA inhibitors is feasible. For all inhibitors studied, the
TNP substituent was substantially less effective in increas-
ing nucleotide affinity than MANT/ANT. Whereas ANT-ATP
was more potent than MANT-ATP, the MANT group was
superior to ANT in case of MANT-GTP versus ANT-GTP. The
additional methyl group in MANT compared with ANT may
reduce mobility of the fluorescent group and thereby facili-
tate alignment with Phe306, depending on the specific
nucleobase present.
For all MANT-NDP/NTP pairs studied so far, elimination
of the -phosphate group substantially decreased inhibitor
affinity. As an example, MANT-IDP (18) was almost 20-fold
less potent than MANT-ITP (12), and the omission of the
-phosphate in MANT-IMP (30) further reduced affinity
compared with MANT-IDP. The importance of the polypho-
sphate chain for effective interaction of nucleotides with the
catalytic site is also supported by our modeling data (Fig.
6B). For future applications of MANT nucleotides in intact-
cell assays, a nucleotide with a phosphate tail resistant to
hydrolysis is needed (Rottlaender et al., 2007). As the potency
of S-substituted MANT nucleotides was higher in case of
MANT-ATPS versus MANT-ATP and MANT-GTPS versus
MANT-GTP, the design of potent nucleotides resistant to
hydrolysis is feasible.
An unexpected side product in our synthesis scheme of
MANT-ITP (12) was di-MANT-IMP (31). Even more unexpect-
edly, addition of a second MANT group to the ribosyl ring in
di-MANT-IMP (31) caused an increase in affinity compared
with MANT-IMP (30) under Mn2 and Mg2 conditions (Table
1) that may be attributed to interactions of the 2MANT group
with a hydrophobic site consisting of Pro305 and Phe261 (Fig.
6B). Thus, the introduction of a second MANT/ANT group or
other bulky substituents should be considered in future inhib-
itor design projects to increase inhibitor affinity. In addition,
given the surprising differences in fluorescence responses be-
tween MANT and TNP nucleotides, di-MANT nucleotides may
provide valuable conformational probes to better understand
the mechanisms of CyaA activation.
Considering the bases, hypoxanthine is superior to other
purine and pyrimidine bases (Table 1). Moreover, 2MANT-
3d-ATP and 3MANT-2d-ATP are considerably more potent
than MANT-ATP. Therefore, 2MANT-3d-ITP and 3MANT-
2d-ITP are interesting future candidates as potential novel
CyaA inhibitors. Further increase in potency and selectivity
of PMEApp may be achieved by changing the adenine base to
hypoxanthine and by introducing a MANT/ANT substituent.
Like CyaA, Bacillus anthracis AC toxin edema factor also
bears a phenylalanine residue close to the catalytic site (Guo
et al., 2005). Structural comparison of CyaA with edema
factor revealed that Phe306 of CyaA is the analog of Phe586
in edema factor, forming hydrophobic interactions with the
MANT group, thus increasing direct fluorescence of MANT
nucleotides. The inhibitory profile of edema factor differs
considerably from that of CyaA. In particular, MANT-ATP
inhibits catalytic activity of CyaA with almost 25-fold lower
potency than catalysis by edema factor (Gille et al., 2004). In
the case of 3MANT-2d-GTP, 3MANT-2d-ATP, and MANT-
ADP, the decreases in potency of CyaA inhibition compared
with edema factor inhibition were 22-, 25-, and 40-fold, re-
spectively. Based on these differences in enzymological prop-
erties, it is also reasonable to assume that the fluorescence
analysis of edema factor with MANT and TNP nucleotides
will give very different results than with CyaA.
We have solved the crystal structure of mammalian C1:C2
AC in complex with MANT-GTP, MANT-ATP, and TNP-ATP
(Mou et al., 2005, 2006). Based on crystallographic studies,
we have developed a tripartite model for mammalian AC
with a binding site for the base, the ribosyl substituent, and
the phosphate tail (Mou et al., 2005, 2006). In this model, the
base site possesses the smallest influence, whereas the ribo-
syl substituent has a strong impact. This model can also be
applied to CyaA (Fig. 6). In particular, a variety of purine and
pyrimidine nucleotides inhibit CyaA, suggesting that the
base does not greatly determine the potency of 2,3-ribosyl
substituted inhibitors. In contrast, introduction of a MANT/
ANT group increased inhibitor potency at CyaA up to 170-
fold (e.g., ITP versus MANT-ITP), pointing to the critical
importance of the ribosyl substituent. However, TNP substi-
tution showed a much smaller effect on inhibitor affinity for
CyaA than for C1:C2 (Mou et al., 2006) (Table 1), highlight-
ing the substantial structural differences between the
binding. In particular, mammalian AC possesses a large
hydrophobic pocket consisting of several amino acids accom-
modating the 2,3-ribosyl substituent (Mou et al., 2005,
2006), whereas in case of CyaA, just one amino acid, Phe306,
participates in hydrophobic interactions with MANT and
TNP nucleotides (Fig. 6).
The Role of Divalent Cations. It is also important to
emphasize that in future studies, inhibitors should be stud-
ied both under Mg2- and Mn2-conditions because there are
differences in the rank order of potency of compounds under
those conditions. Moreover, exchange of Mn2 against Mg2
increases Vmax and decreases Km (Table 1). Crystallographic
studies are required to understand those substantial differ-
ences between Mn2 and Mg2. It is reasonable to assume
that under physiological conditions, Mg2 rather than Mn2
is relevant. It is most likely that Mn2 is only an (important)
experimental tool to facilitate molecular analysis of CyaA. In
particular, in the presence of Mg2, detection of significant
increases in FRET and direct fluorescence with MANT nu-
cleotides was impossible (data not shown).
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CaM-Independent Interaction of CyaA with Nucleo-
tides. The fact that fluorescence of TNP nucleotides in-
creased upon interaction with CyaA in the absence of the
activator CaM (Fig. 5) indicates that the nucleotide-binding
site of CyaA is already functional in the catalytically inactive
toxin. However, our data suggest that CyaA does not bind
MANT nucleotides in the absence of CaM, because FRET and
direct fluorescence with MANT nucleotides was completely
dependent on CaM (Figs. 1–4). In contrast to CyaA, mamma-
lian C1:C2 does bind MANT nucleotides, to some extent, in
the absence of the activator forskolin (Mou et al., 2005, 2006),
again supporting the concept of substantial structural differ-
ences between mammalian and bacterial AC. These data also
imply that binding of CaM to CyaA induces a conformational
change in the toxin that allows MANT nucleotides to bind.
The identification of the precise nature of this conformational
change requires crystallization of CyaA complexes with TNP
nucleotides in the absence and presence of CaM as well as of
CyaA with MANT nucleotides in the presence of CaM. The
opposite fluorescence responses of TNP nucleotides and
MANT nucleotides to CaM are in agreement with the mod-
eling studies showing that the TNP and MANT groups adopt
similar but not identical positions in the catalytic site of
CyaA (Fig. 6D). The dramatic differences in fluorescence
responses of TNP- and MANT nucleotides in the absence and
presence of CaM also demonstrate that these nucleotides are
extremely sensitive probes for detecting small differences in
nucleotide/CyaA interactions.
Another implication of the CaM-independent binding of
TNP nucleotides to CyaA is that the catalytic site of CyaA
possesses different binding properties than the site in the
presence of CaM, offering additional possibilities for inhibitor
design and increasing inhibitor selectivity. Comparison of
inhibition profiles of nonfluorescent nucleotides on TNP nu-
cleotide fluorescence bound to CyaA in the absence and pres-
ence of CaM is a feasible approach. With respect to catalysis,
such comparison is impossible because enzymatic activity
obligatorily depends on CaM (Ladant and Ullmann, 1999;
Shen et al., 2002).
Conclusions
In the present study, we have shown that the catalytic site of
CyaA possesses unique pharmacological properties compared
with other mammalian and bacterial ACs. The spacious cata-
lytic site of CyaA accommodates a broad variety of 2,3-substi-
tuted nucleotides, even di-MANT nucleotides. Some inhibitors
can bind to CyaA even in the absence of CaM, and there is
evidence for distinct interaction of CyaA with MANT nucleo-
tides and TNP nucleotides. Finally, the fluorescence assays
described in this study can be used for identification of novel
CyaA inhibitors, ultimately resulting in the development of
novel drugs for prophylaxis of whooping cough.
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